Orphan designation: Dersimelagon Treatment of erythropoietic protoporphyria, 16/03/2022 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 7 December 2023 - 7:46

Orphan designation: Dersimelagon Treatment of erythropoietic protoporphyria, 16/03/2022 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2585

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters